The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin.
AUTOR(ES)
Eichelbaum, Michel
FONTE
American Society for Clinical Investigation
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=150427Documentos Relacionados
- The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin
- Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833.
- Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein
- Association between the number of coadministered P-glycoprotein inhibitors and serum digoxin levels in patients on therapeutic drug monitoring
- Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.